000 | 01531 a2200433 4500 | ||
---|---|---|---|
005 | 20250514020510.0 | ||
264 | 0 | _c20020115 | |
008 | 200201s 0 0 eng d | ||
022 | _a0093-7754 | ||
024 | 7 |
_a10.1016/s0093-7754(01)90022-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVacca, A | |
245 | 0 | 0 |
_aBone marrow angiogenesis in patients with active multiple myeloma. _h[electronic resource] |
260 |
_bSeminars in oncology _cDec 2001 |
||
300 |
_a543-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAngiogenesis Inducing Agents _xmetabolism |
650 | 0 | 4 | _aAquaporin 1 |
650 | 0 | 4 |
_aAquaporins _xmetabolism |
650 | 0 | 4 | _aBlood Group Antigens |
650 | 0 | 4 |
_aBone Marrow _xblood supply |
650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoenzyme Techniques |
650 | 0 | 4 |
_aMast Cells _xmetabolism |
650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xmetabolism |
650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xmetabolism |
650 | 0 | 4 |
_aMultiple Myeloma _xblood supply |
650 | 0 | 4 | _aNeovascularization, Pathologic |
650 | 0 | 4 |
_aParaproteinemias _xmetabolism |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aThromboplastin _xmetabolism |
700 | 1 | _aRibatti, D | |
700 | 1 | _aRoccaro, A M | |
700 | 1 | _aFrigeri, A | |
700 | 1 | _aDammacco, F | |
773 | 0 |
_tSeminars in oncology _gvol. 28 _gno. 6 _gp. 543-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0093-7754(01)90022-3 _zAvailable from publisher's website |
999 |
_c11654041 _d11654041 |